Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
0.96
0.01 (1.23%)
At close: Aug 18, 2025, 3:59 PM
0.98
1.76%
Pre-market: Aug 19, 2025, 06:03 AM EDT
Tevogen Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -35.38M | -14.51M | -5.89M | -3.89M | -16.41M | -57.67M | -54.23M | -48.71M | -26.32M | 4.41M | 1.78M | 163.68K | -43.32K | -17.33K |
Depreciation & Amortization | 410.68K | 403.58K | 559.18K | 538.27K | 543.73K | 536.64K | 473.55K | 277.62K | 289.36K | 198.15K | 2.1K | n/a | n/a | n/a |
Stock-Based Compensation | 21.72M | 40.76M | 32.8M | 29.48M | 26.33M | n/a | 720.82K | 1.98M | 1.98M | 1.98M | 1.26M | n/a | n/a | n/a |
Other Working Capital | 598.32K | -231.36K | -1.77M | -1.36M | -1.36M | -34.33K | 313.5K | 305.93K | 628.78K | 566.61K | -165.43K | -249.25K | -491.56K | -571.78K |
Other Non-Cash Items | 8.23M | -39.45M | -37.03M | -35.23M | -18.76M | 50.05M | 47.15M | 43.79M | 23.25M | -5.53M | -2.87M | -984.08K | -548.12K | -201.61K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -867.66K | n/a | -756.98K | 822.99K | 777.15K | 315.11K | 560.24K | 285.09K | 623.64K | 737.69K | 5.43K | -150.8K | -363.49K | -533.33K |
Operating Cash Flow | -13.14M | -12M | -9.64M | -7.64M | -6.88M | -6.89M | -6.21M | -4.45M | -2.28M | -215.4K | -915.36K | -872.76K | -826.86K | -713.83K |
Capital Expenditures | 3.00 | n/a | n/a | n/a | n/a | -133K | -298.39K | -425.02K | -425.02K | -292.02K | -126.64K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -67.5K | -67.5K | -67.5K | -67.5K | n/a | n/a | n/a | n/a | -351.9M | -351.9M | -351.9M | -351.9M |
Sales Maturities Of Investments | n/a | n/a | 9.71M | 9.71M | 9.71M | 342.98M | 333.27M | 333.27M | 333.27M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 9.65M | 9.65M | 9.65M | 9.51M | -298.39K | -425.02K | -425.02K | -292.02K | -352.03M | -351.9M | -351.9M | -351.9M |
Debt Repayment | 3M | 1M | 1.35M | 1.5M | 2.4M | 4.9M | 7.05M | 5.9M | 5M | 2.5M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 323.89M | -342.98M | -342.98M | -342.98M | -333.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 16.8M | 15.03M | 4.1M | 2.9M | 101.83K | -127.5K | -200K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 13.8M | 12.23M | 938.05K | -3.11M | -5.01M | -4.94M | 6.85M | 5.9M | 5M | 2.5M | 352.96M | 352.96M | 352.96M | 352.96M |
Net Cash Flow | 657.03K | 230.6K | 939.57K | -1.11M | -3.14M | -3.22M | -2.89M | -2.08M | 87.5K | -215.4K | 143.05K | 185.64K | 231.54K | 344.58K |
Free Cash Flow | -13.14M | -12M | -9.64M | -7.64M | -6.88M | -7.02M | -6.51M | -4.88M | -2.7M | -507.42K | -1.04M | -872.76K | -826.86K | -713.83K |